Quantitative measurements of mean time to death, percentage of survivors, and viable cell populations in the whole body were employed to determine the effects of penicillin, dihydrostreptomycin, chlortetracycline, oxytetracycline, chloramphenicol, and antiserum on the course of anthrax infection in mice. By all parameters tested, penicillin and dihydrostreptomycin were most effective in the treatment of the disease. Therapy initiated in the later stages of the disease was more effective than that initiated in the earlier stages. Quantitative studies indicated that it was more difficult to eliminate organisms from the kidney than from any other organ or tissue. These measurements for the evaluation of antibiotic therapy are suggested for the study of other bacterial diseases.
The successful treatment of bacterial infections depends upon the elimination of the organisms from the various organs of the host and, in most cases, the neutralization of metabolic products of the organism. Investigations of anthrax populations in organs thus far have been limited to the last few hours before death (7) . Other attempts to measure in vivo growth of Bacillus anthracis in the whole body have met with limited success (1, 2, 8, 9, 11, 13) , mainly because the techniques did not include quantitation of bacterial populations in the whole body throughout the course of the disease. We have reported (8, 10, 12) on the quantitation of anthrax septicemia in various laboratory animals, and observed differences in growth rates and terminal organism populations.
This paper evaluates the effectiveness of antibiotic and antitoxin therapy by use of measurements of mean time to death (MTD) in anthrax infection and quantitation of bacterial populations in the whole body. The effect of antibiotics administered at various stages of the disease revealed vast differences in their effectiveness not otherwise demonstrable. These differences in effect of antibiotics, we believe, enable us to understand better the dynamics of the disease and its therapy.
MATERIALS AND METHODS
Animals. Inbred mice, 18 to 20 g, of the BALB strain were used.
Challenge organism. Washed spores of the highly virulent Vollum (Vlb) strain of B. anthracis were used for MTD studies. In the in vivo growth studies, spores were germinated for 30 min in a medium composed of 0.00375% L-alanine, 0.00375% L-tyrosine, 0.001875% adenosine, 0.07% Beef Extract (Difco) and 0.15% peptone (Difco), at a pH of 6.8 to 7.2. The stage of germination was determined as follows: (i) Under dark field microscopy, loss of spore refractility was observed. (ii) Under light microscopy, resistance to spore stains and susceptibility to Gram stain was observed. There was no evidence of outgrowth of a vegetative cell.
Differential plate counts before and after the addition of sufficient phenol to obtain a final concentration of 1% (4) revealed 99.9% germination. Preliminary laboratory studies of the effect of tissue homogenates on germinated spores indicated the necessity of adding Beef Extract and peptone to effect 100% recovery of viable organisms. A dose of 105 organisms was inoculated by the intraperitoneal route.
Treatment. The single-dose therapy and initial treatment, when maintenance doses were to be given, consisted of 1,000 units of penicillin, 0.4 mg of dihydrostreptomycin, 0.4 mg of chlortetracycline, 0.4 mg of oxytetracycline, 0.4 mg of chloramphenicol, and 0.3 ml of a 1:10 dilution of anthrax antiserum prepared in horses against the Sterne strain of B. anthracis (Instituto Seraterapico Tuscano, Sienna, Italy). Each milliliter of antiserum neutralized approximately 7,000 rat units of in vitro toxin (6 Treatment with chlortetracycline, dihydrostreptomycin, and oxytetracycline resulted in approximately 13% survival. The extension of the MTD was 2.5-fold for the chlortetracycline group, 1.5-fold for the dihydrostreptomycin-treated animals, and 1.0-fold for the oxytetracycline group. These differences in MTD were significant at the 0.01 % level. Chloramphenicol had no effect on course of anthrax in the mouse when treatment was initiated 4 tion of crystalline penicillin showed that penicillin eliminated the organisms in the spleen, liver, blood, and lungs, but the carcass and kidney still had a substantial level of organisms at the end of the sampling periods. After administration of chlortetracycline, the growth curve for the in vivo bacilli revealed that all tissues contained residual organisms at 16 hr after treatment. The growth curves for bacilli in animals treated with oxytetracycline showed that, during the 16 hr after treatment, all tissues with the exception of the carcass contained a substantial number of organisms. Penicillin was the most effective antibiotic to reduce organism numbers; it was followed by chlortetracylcine in effectiveness.
Peritoneal cavity clearance. Periodic examination of the peritoneal cavity for the presence of challenge organisms revealed that more than 50% of the organisms had been removed or destroyed in situ within 40 min postchallenge (Fig. 4) . This reduction was a continuing process, so that at 6 hr only 0.7 % of the challenge dose was found in the peritoneum. In the course of our whole body studies, we were able to detect organisms in all tissues 20 min after challenge. Bonventre et al. (2) , by an autoradiographic technique, observed the presence of organisms in the organs of the reticuloendothelial system 30 min after challenge. In contrast, Krazilnikov and Izraitel (11), using a comparable dose, were not able to detect the presence of B. anthracis in the various organs of the nonirradiated host until 36 to 48 hr after the onset of infection. We believe that the large discrepancy in the time required for dissemination of bacilli into the various organs of the host may result from differences in any or all of several factors: (i) virulence of organism, (ii) species or strain of host, (iii) route of challenge, (iv) dose, and (v) sensitivity of the assay.
DISCUSSION
The kidney is well known in medical literature for harboring chronic infections that are extremely difficult to treat, and, with anthrax, the kidney still harbors organisms after a single injection of either the effective or noneffective antibiotics. In the remaining organs, some of the less effective antibiotics eliminated the organisms more readily. We suggest that this organ should always be assayed in cases of death when antibiotics have been used and when anthrax is suspected, or when making a selection of antibiotics to be used in the treatment of anthrax and other diseases. A 1.5 log higher level of organisms was obtained in the blood terminally after treatment with antiserum as compared to the untreated control hosts without a correspondingly higher level of organisms in the organs. Since antiserum would neutralize toxin in the blood and prevent attachment to sensitive sites, this observation suggests that the toxin found in the blood at death was produced by the organisms in the blood, and that the organisms in the organs and fixed sites have a relatively delayed effect on the host.
